Suppr超能文献

AKR.H-2b:Fv-1b小鼠对AKR/格罗斯白血病病毒无反应性的机制。年轻与中年小鼠中前体细胞毒性T淋巴细胞频率的分析。

Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.

作者信息

Wegmann K W, McMaster J S, Green W R

机构信息

Department of Microbiology, Dartmouth Medical School, Hanover, NH 03756.

出版信息

J Immunol. 1991 Apr 1;146(7):2469-77.

PMID:2005406
Abstract

As young adult AKR.H-2b:Fv-1b mice reach about 9 wk of age, they begin to develop a nonresponsiveness to AKR/Gross leukemia virus. Unlike young mice that are responders, moderately aged AKR.H-2b:Fv-1b mice, after immunization and secondary in vitro restimulation in bulk culture with AKR/Gross virus induced tumors, can not generate anti-AKR/Gross virus-specific CTL. The mechanism of conversion to nonresponsiveness in moderately aged AKR.H-2b:Fv-1b mice is not understood, but it is correlated with increased expression of endogenous ecotropic viral antigens. Our present investigation focuses on determining the frequency of anti-AKR/Gross virus precursor CTL in AKR.H-2b:Fv-1b mice as a function of age. This was achieved by performing limiting dilution cultures of immune spleen cells obtained from young and moderately aged AKR.H-2b:Fv-1b mice. Although spleen cells obtained from immune moderately aged mice can not differentiate in bulk cultures into anti-AKR/Gross virus-specific CTL, there was no evidence of substantially decreased frequencies of virus-specific precursor CTL, relative to precursor CTL frequencies observed in young responder AKR.H-2b:Fv-1b mice.

摘要

当年轻的成年AKR.H-2b:Fv-1b小鼠长到约9周龄时,它们开始对AKR/格罗斯白血病病毒产生无反应性。与有反应的年轻小鼠不同,中等年龄的AKR.H-2b:Fv-1b小鼠在免疫并用AKR/格罗斯病毒诱导的肿瘤进行体外二次再刺激后,无法产生抗AKR/格罗斯病毒特异性CTL。中等年龄的AKR.H-2b:Fv-1b小鼠转变为无反应性的机制尚不清楚,但它与内源性嗜亲性病毒抗原表达的增加有关。我们目前的研究重点是确定AKR.H-2b:Fv-1b小鼠中抗AKR/格罗斯病毒前体CTL的频率随年龄的变化情况。这是通过对从年轻和中等年龄的AKR.H-2b:Fv-1b小鼠获得的免疫脾细胞进行有限稀释培养来实现的。尽管从免疫的中等年龄小鼠获得的脾细胞在大量培养中不能分化为抗AKR/格罗斯病毒特异性CTL,但相对于在年轻有反应的AKR.H-2b:Fv-1b小鼠中观察到的前体CTL频率,没有证据表明病毒特异性前体CTL的频率大幅下降。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验